Patients affected by hereditary AD, which is typically caused by mutations in the amyloid precursor protein (APP), presenilin-1 (PS1), and/or presenilin-2 (PS2) genes, are a particularly seizure-prone population, with seizures rates higher than 30% [29]. This evidence concerns the gene PSEN2 and Alzheimer disease.